YPSNZ Stock Overview
Develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Ypsomed Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 365.50 |
| 52 Week High | CHF 439.00 |
| 52 Week Low | CHF 288.50 |
| Beta | 0.99 |
| 1 Month Change | 0.14% |
| 3 Month Change | -12.35% |
| 1 Year Change | 22.86% |
| 3 Year Change | 106.96% |
| 5 Year Change | n/a |
| Change since IPO | 572.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| YPSNZ | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0.8% | -2.0% | -1.4% |
| 1Y | 22.9% | -7.9% | 4.6% |
Return vs Industry: YPSNZ exceeded the UK Medical Equipment industry which returned -6.6% over the past year.
Return vs Market: YPSNZ exceeded the UK Market which returned 17.5% over the past year.
Price Volatility
| YPSNZ volatility | |
|---|---|
| YPSNZ Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: YPSNZ has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: YPSNZ's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 2,600 | Simon Michel | www.ypsomed.com |
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices.
Ypsomed Holding AG Fundamentals Summary
| YPSNZ fundamental statistics | |
|---|---|
| Market cap | CHF 4.99b |
| Earnings (TTM) | CHF 74.39m |
| Revenue (TTM) | CHF 617.07m |
67.1x
P/E Ratio8.1x
P/S RatioIs YPSNZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YPSNZ income statement (TTM) | |
|---|---|
| Revenue | CHF 617.07m |
| Cost of Revenue | CHF 398.41m |
| Gross Profit | CHF 218.66m |
| Other Expenses | CHF 144.28m |
| Earnings | CHF 74.39m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.45 |
| Gross Margin | 35.44% |
| Net Profit Margin | 12.05% |
| Debt/Equity Ratio | 52.3% |
How did YPSNZ perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield37%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/17 16:19 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ypsomed Holding AG is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Carla Bänziger | Bank Vontobel AG |
| Gaurav Jain | Barclays |
| Curtis Moiles | BNP Paribas Exane |